SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 58.17+3.9%Dec 4 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (6308)5/10/2002 10:40:02 AM
From: Ian@SI  Read Replies (1) of 52153
 
You jumped the gun on VPHM. There will be another selloff when the FDA rejection gets documented in the 10Q! ;-) And then another one a few weeks later when some reporter takes the 10Q statement and reports it as "new" news.

The constant press on rising drug costs, reticence by Medicare/Medicaid to cover new drugs and the resultant slow uptake on new treatments such as Xigris certainly isn't helping the sector.

But this too, shall pass.

I hope. <g>

Ian
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News